gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
US5739306A · kind A · utility
6Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 1996 |
| Grant date | Apr 14, 1998 |
| Priority date | — |
| Expiry date | Sep 9, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are immunogens and peptides based on the binding site of gC1q-R for HIV-1 gp120, and immunogens and peptides based on the binding site of HIV-1 gp120 for gC1q-R. The sequence of the gC1q-R binding site for gp120 is shown in SEQ ID NO.: 2. The sequence of the HIV-1 gp120 binding site for gC1q-R is shown in SEQ ID NO.: 3. Also disclosed are antibodies and binding molecules to all such immunogens and peptides, and inducing the endogenous production of such antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.